ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEF2D
|
ENSG00000116604.13 | MEF2D |
MEF2A
|
ENSG00000068305.13 | MEF2A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MEF2A | hg19_v2_chr15_+_100106155_100106243 | 0.58 | 1.9e-02 | Click! |
MEF2D | hg19_v2_chr1_-_156460391_156460417, hg19_v2_chr1_-_156470556_156470643 | 0.19 | 4.8e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_201391149 | 12.28 |
ENST00000555948.1 ENST00000556362.1 |
TNNI1 |
troponin I type 1 (skeletal, slow) |
chr5_-_111091948 | 9.25 |
ENST00000447165.2 |
NREP |
neuronal regeneration related protein |
chr2_-_211168332 | 8.84 |
ENST00000341685.4 |
MYL1 |
myosin, light chain 1, alkali; skeletal, fast |
chr3_+_138067521 | 8.26 |
ENST00000494949.1 |
MRAS |
muscle RAS oncogene homolog |
chr10_-_75415825 | 7.41 |
ENST00000394810.2 |
SYNPO2L |
synaptopodin 2-like |
chr5_+_53751445 | 7.40 |
ENST00000302005.1 |
HSPB3 |
heat shock 27kDa protein 3 |
chr3_-_52486841 | 7.27 |
ENST00000496590.1 |
TNNC1 |
troponin C type 1 (slow) |
chrX_-_21776281 | 7.24 |
ENST00000379494.3 |
SMPX |
small muscle protein, X-linked |
chr2_-_190044480 | 5.95 |
ENST00000374866.3 |
COL5A2 |
collagen, type V, alpha 2 |
chr3_+_138067314 | 5.54 |
ENST00000423968.2 |
MRAS |
muscle RAS oncogene homolog |
chr3_+_138067666 | 5.39 |
ENST00000475711.1 ENST00000464896.1 |
MRAS |
muscle RAS oncogene homolog |
chr2_-_211179883 | 5.14 |
ENST00000352451.3 |
MYL1 |
myosin, light chain 1, alkali; skeletal, fast |
chr1_-_116311402 | 5.08 |
ENST00000261448.5 |
CASQ2 |
calsequestrin 2 (cardiac muscle) |
chr10_-_75410771 | 4.63 |
ENST00000372873.4 |
SYNPO2L |
synaptopodin 2-like |
chr2_+_170366203 | 4.52 |
ENST00000284669.1 |
KLHL41 |
kelch-like family member 41 |
chr1_+_114522049 | 4.22 |
ENST00000369551.1 ENST00000320334.4 |
OLFML3 |
olfactomedin-like 3 |
chr12_+_119616447 | 3.91 |
ENST00000281938.2 |
HSPB8 |
heat shock 22kDa protein 8 |
chr4_+_41362796 | 3.81 |
ENST00000508501.1 ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1 |
LIM and calponin homology domains 1 |
chr5_-_150521192 | 3.80 |
ENST00000523714.1 ENST00000521749.1 |
ANXA6 |
annexin A6 |
chr1_-_173174681 | 3.77 |
ENST00000367718.1 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
chr1_-_201390846 | 3.66 |
ENST00000367312.1 ENST00000555340.2 ENST00000361379.4 |
TNNI1 |
troponin I type 1 (skeletal, slow) |
chr20_+_9049682 | 3.34 |
ENST00000334005.3 ENST00000378473.3 |
PLCB4 |
phospholipase C, beta 4 |
chr1_-_153518270 | 3.28 |
ENST00000354332.4 ENST00000368716.4 |
S100A4 |
S100 calcium binding protein A4 |
chr9_-_75567962 | 3.18 |
ENST00000297785.3 ENST00000376939.1 |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
chr3_-_145878954 | 3.05 |
ENST00000282903.5 ENST00000360060.3 |
PLOD2 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
chr17_+_4855053 | 3.03 |
ENST00000518175.1 |
ENO3 |
enolase 3 (beta, muscle) |
chr1_-_201346761 | 2.98 |
ENST00000455702.1 ENST00000422165.1 ENST00000367318.5 ENST00000367320.2 ENST00000438742.1 ENST00000412633.1 ENST00000458432.2 ENST00000421663.2 ENST00000367322.1 ENST00000509001.1 |
TNNT2 |
troponin T type 2 (cardiac) |
chr17_-_10325261 | 2.97 |
ENST00000403437.2 |
MYH8 |
myosin, heavy chain 8, skeletal muscle, perinatal |
chr4_-_186697044 | 2.96 |
ENST00000437304.2 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr12_-_111358372 | 2.87 |
ENST00000548438.1 ENST00000228841.8 |
MYL2 |
myosin, light chain 2, regulatory, cardiac, slow |
chr2_+_233497931 | 2.85 |
ENST00000264059.3 |
EFHD1 |
EF-hand domain family, member D1 |
chr5_+_155753745 | 2.56 |
ENST00000435422.3 ENST00000337851.4 ENST00000447401.1 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
chr13_+_76334567 | 2.52 |
ENST00000321797.8 |
LMO7 |
LIM domain 7 |
chr13_-_67802549 | 2.52 |
ENST00000328454.5 ENST00000377865.2 |
PCDH9 |
protocadherin 9 |
chr12_-_91539918 | 2.52 |
ENST00000548218.1 |
DCN |
decorin |
chr1_-_203144941 | 2.52 |
ENST00000255416.4 |
MYBPH |
myosin binding protein H |
chr13_+_76334795 | 2.49 |
ENST00000526202.1 ENST00000465261.2 |
LMO7 |
LIM domain 7 |
chr3_+_99357319 | 2.47 |
ENST00000452013.1 ENST00000261037.3 ENST00000273342.4 |
COL8A1 |
collagen, type VIII, alpha 1 |
chr1_+_145524891 | 2.47 |
ENST00000369304.3 |
ITGA10 |
integrin, alpha 10 |
chr4_+_120056939 | 2.36 |
ENST00000307128.5 |
MYOZ2 |
myozenin 2 |
chr10_+_88428206 | 2.35 |
ENST00000429277.2 ENST00000458213.2 ENST00000352360.5 |
LDB3 |
LIM domain binding 3 |
chr11_+_1942580 | 2.34 |
ENST00000381558.1 |
TNNT3 |
troponin T type 3 (skeletal, fast) |
chr4_-_143226979 | 2.24 |
ENST00000514525.1 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chrX_+_153046456 | 2.14 |
ENST00000393786.3 ENST00000370104.1 ENST00000370108.3 ENST00000370101.3 ENST00000430541.1 ENST00000370100.1 |
SRPK3 |
SRSF protein kinase 3 |
chr6_+_132129151 | 2.14 |
ENST00000360971.2 |
ENPP1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
chr4_+_169418195 | 2.13 |
ENST00000261509.6 ENST00000335742.7 |
PALLD |
palladin, cytoskeletal associated protein |
chr10_-_95241951 | 2.11 |
ENST00000358334.5 ENST00000359263.4 ENST00000371488.3 |
MYOF |
myoferlin |
chr10_-_95242044 | 2.10 |
ENST00000371501.4 ENST00000371502.4 ENST00000371489.1 |
MYOF |
myoferlin |
chr2_+_220283091 | 2.09 |
ENST00000373960.3 |
DES |
desmin |
chr9_+_139871948 | 2.07 |
ENST00000224167.2 ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS |
prostaglandin D2 synthase 21kDa (brain) |
chr11_+_1940925 | 2.05 |
ENST00000453458.1 ENST00000381557.2 ENST00000381589.3 ENST00000381579.3 ENST00000381563.4 ENST00000344578.4 |
TNNT3 |
troponin T type 3 (skeletal, fast) |
chr10_-_62704005 | 2.05 |
ENST00000337910.5 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
chr16_+_7382745 | 1.95 |
ENST00000436368.2 ENST00000311745.5 ENST00000355637.4 ENST00000340209.4 |
RBFOX1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr11_+_112832202 | 1.95 |
ENST00000534015.1 |
NCAM1 |
neural cell adhesion molecule 1 |
chr9_+_116327326 | 1.94 |
ENST00000342620.5 |
RGS3 |
regulator of G-protein signaling 3 |
chr3_+_8543393 | 1.91 |
ENST00000157600.3 ENST00000415597.1 ENST00000535732.1 |
LMCD1 |
LIM and cysteine-rich domains 1 |
chr2_-_106054952 | 1.87 |
ENST00000336660.5 ENST00000393352.3 ENST00000607522.1 |
FHL2 |
four and a half LIM domains 2 |
chr4_-_186696425 | 1.84 |
ENST00000430503.1 ENST00000319454.6 ENST00000450341.1 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr1_-_31845914 | 1.79 |
ENST00000373713.2 |
FABP3 |
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) |
chr3_+_8543561 | 1.76 |
ENST00000397386.3 |
LMCD1 |
LIM and cysteine-rich domains 1 |
chr3_-_114343039 | 1.76 |
ENST00000481632.1 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr5_-_42811986 | 1.75 |
ENST00000511224.1 ENST00000507920.1 ENST00000510965.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chrX_+_70521584 | 1.70 |
ENST00000373829.3 ENST00000538820.1 |
ITGB1BP2 |
integrin beta 1 binding protein (melusin) 2 |
chr2_-_151344172 | 1.68 |
ENST00000375734.2 ENST00000263895.4 ENST00000454202.1 |
RND3 |
Rho family GTPase 3 |
chr11_+_1860200 | 1.63 |
ENST00000381911.1 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
chr5_-_42812143 | 1.61 |
ENST00000514985.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chr6_-_169654139 | 1.60 |
ENST00000366787.3 |
THBS2 |
thrombospondin 2 |
chr17_-_10421853 | 1.57 |
ENST00000226207.5 |
MYH1 |
myosin, heavy chain 1, skeletal muscle, adult |
chr12_+_81101277 | 1.55 |
ENST00000228641.3 |
MYF6 |
myogenic factor 6 (herculin) |
chr7_-_150946015 | 1.55 |
ENST00000262188.8 |
SMARCD3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
chr11_+_12399071 | 1.54 |
ENST00000539723.1 ENST00000550549.1 |
PARVA |
parvin, alpha |
chr11_+_112832133 | 1.53 |
ENST00000524665.1 |
NCAM1 |
neural cell adhesion molecule 1 |
chr4_+_169418255 | 1.49 |
ENST00000505667.1 ENST00000511948.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr5_-_88179302 | 1.46 |
ENST00000504921.2 |
MEF2C |
myocyte enhancer factor 2C |
chr10_+_88428370 | 1.35 |
ENST00000372066.3 ENST00000263066.6 ENST00000372056.4 ENST00000310944.6 ENST00000361373.4 ENST00000542786.1 |
LDB3 |
LIM domain binding 3 |
chr11_+_12766583 | 1.34 |
ENST00000361985.2 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr8_+_1993152 | 1.33 |
ENST00000262113.4 |
MYOM2 |
myomesin 2 |
chr3_+_8543533 | 1.33 |
ENST00000454244.1 |
LMCD1 |
LIM and cysteine-rich domains 1 |
chr16_+_6069072 | 1.33 |
ENST00000547605.1 ENST00000550418.1 ENST00000553186.1 |
RBFOX1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr3_+_179370517 | 1.30 |
ENST00000263966.3 |
USP13 |
ubiquitin specific peptidase 13 (isopeptidase T-3) |
chr15_+_100106126 | 1.29 |
ENST00000558812.1 ENST00000338042.6 |
MEF2A |
myocyte enhancer factor 2A |
chr17_+_68165657 | 1.29 |
ENST00000243457.3 |
KCNJ2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
chr14_-_102704783 | 1.28 |
ENST00000522534.1 |
MOK |
MOK protein kinase |
chr17_-_1389419 | 1.26 |
ENST00000575158.1 |
MYO1C |
myosin IC |
chr17_-_1389228 | 1.24 |
ENST00000438665.2 |
MYO1C |
myosin IC |
chr3_+_135741576 | 1.22 |
ENST00000334546.2 |
PPP2R3A |
protein phosphatase 2, regulatory subunit B'', alpha |
chr11_+_112832090 | 1.22 |
ENST00000533760.1 |
NCAM1 |
neural cell adhesion molecule 1 |
chr1_-_154164534 | 1.21 |
ENST00000271850.7 ENST00000368530.2 |
TPM3 |
tropomyosin 3 |
chrX_-_128657457 | 1.20 |
ENST00000371121.3 ENST00000371123.1 ENST00000371122.4 |
SMARCA1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr15_+_100106244 | 1.18 |
ENST00000557942.1 |
MEF2A |
myocyte enhancer factor 2A |
chr7_-_134143841 | 1.15 |
ENST00000285930.4 |
AKR1B1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
chr3_+_35721106 | 1.15 |
ENST00000474696.1 ENST00000412048.1 ENST00000396482.2 ENST00000432682.1 |
ARPP21 |
cAMP-regulated phosphoprotein, 21kDa |
chr8_+_1993173 | 1.13 |
ENST00000523438.1 |
MYOM2 |
myomesin 2 |
chr18_-_53070913 | 1.11 |
ENST00000568186.1 ENST00000564228.1 |
TCF4 |
transcription factor 4 |
chr11_+_1860832 | 1.08 |
ENST00000252898.7 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
chr4_-_143767428 | 1.06 |
ENST00000513000.1 ENST00000509777.1 ENST00000503927.1 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr17_+_80186908 | 1.06 |
ENST00000582743.1 ENST00000578684.1 ENST00000577650.1 ENST00000582715.1 |
SLC16A3 |
solute carrier family 16 (monocarboxylate transporter), member 3 |
chr15_+_100106155 | 1.05 |
ENST00000557785.1 ENST00000558049.1 ENST00000449277.2 |
MEF2A |
myocyte enhancer factor 2A |
chr1_-_59249732 | 1.04 |
ENST00000371222.2 |
JUN |
jun proto-oncogene |
chr9_-_130639997 | 1.03 |
ENST00000373176.1 |
AK1 |
adenylate kinase 1 |
chr11_+_1860682 | 0.98 |
ENST00000381906.1 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
chr1_+_84630645 | 0.93 |
ENST00000394839.2 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chr12_-_16759711 | 0.91 |
ENST00000447609.1 |
LMO3 |
LIM domain only 3 (rhombotin-like 2) |
chr3_+_159570722 | 0.85 |
ENST00000482804.1 |
SCHIP1 |
schwannomin interacting protein 1 |
chr12_-_9268707 | 0.84 |
ENST00000318602.7 |
A2M |
alpha-2-macroglobulin |
chr17_+_65040678 | 0.81 |
ENST00000226021.3 |
CACNG1 |
calcium channel, voltage-dependent, gamma subunit 1 |
chr4_-_143227088 | 0.79 |
ENST00000511838.1 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr11_+_1940786 | 0.79 |
ENST00000278317.6 ENST00000381561.4 ENST00000381548.3 ENST00000360603.3 ENST00000381549.3 |
TNNT3 |
troponin T type 3 (skeletal, fast) |
chr11_+_65082289 | 0.78 |
ENST00000279249.2 |
CDC42EP2 |
CDC42 effector protein (Rho GTPase binding) 2 |
chr1_+_160085501 | 0.78 |
ENST00000361216.3 |
ATP1A2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr19_+_3933579 | 0.73 |
ENST00000593949.1 |
NMRK2 |
nicotinamide riboside kinase 2 |
chr6_+_41021027 | 0.70 |
ENST00000244669.2 |
APOBEC2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
chr16_-_31439735 | 0.70 |
ENST00000287490.4 |
COX6A2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
chr19_+_3933085 | 0.69 |
ENST00000168977.2 ENST00000599576.1 |
NMRK2 |
nicotinamide riboside kinase 2 |
chr1_-_204329013 | 0.67 |
ENST00000272203.3 ENST00000414478.1 |
PLEKHA6 |
pleckstrin homology domain containing, family A member 6 |
chr4_+_95373037 | 0.67 |
ENST00000359265.4 ENST00000437932.1 ENST00000380180.3 ENST00000318007.5 ENST00000450793.1 ENST00000538141.1 ENST00000317968.4 ENST00000512274.1 ENST00000503974.1 ENST00000504489.1 ENST00000542407.1 |
PDLIM5 |
PDZ and LIM domain 5 |
chr20_+_44519948 | 0.63 |
ENST00000354880.5 ENST00000191018.5 |
CTSA |
cathepsin A |
chr6_+_108977520 | 0.63 |
ENST00000540898.1 |
FOXO3 |
forkhead box O3 |
chr10_-_49860525 | 0.61 |
ENST00000435790.2 |
ARHGAP22 |
Rho GTPase activating protein 22 |
chr1_+_156211753 | 0.59 |
ENST00000368272.4 |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
chr2_+_161993412 | 0.59 |
ENST00000259075.2 ENST00000432002.1 |
TANK |
TRAF family member-associated NFKB activator |
chr2_+_44502597 | 0.57 |
ENST00000260649.6 ENST00000409387.1 |
SLC3A1 |
solute carrier family 3 (amino acid transporter heavy chain), member 1 |
chr20_+_44520009 | 0.55 |
ENST00000607482.1 ENST00000372459.2 |
CTSA |
cathepsin A |
chr17_+_27369918 | 0.53 |
ENST00000323372.4 |
PIPOX |
pipecolic acid oxidase |
chr2_+_161993465 | 0.53 |
ENST00000457476.1 |
TANK |
TRAF family member-associated NFKB activator |
chr1_+_25757376 | 0.52 |
ENST00000399766.3 ENST00000399763.3 ENST00000374343.4 |
TMEM57 |
transmembrane protein 57 |
chr8_-_49834299 | 0.49 |
ENST00000396822.1 |
SNAI2 |
snail family zinc finger 2 |
chr4_+_129730779 | 0.49 |
ENST00000226319.6 |
PHF17 |
jade family PHD finger 1 |
chr9_-_74980113 | 0.48 |
ENST00000376962.5 ENST00000376960.4 ENST00000237937.3 |
ZFAND5 |
zinc finger, AN1-type domain 5 |
chr20_+_1875110 | 0.48 |
ENST00000400068.3 |
SIRPA |
signal-regulatory protein alpha |
chr2_+_85766280 | 0.46 |
ENST00000306434.3 |
MAT2A |
methionine adenosyltransferase II, alpha |
chr8_-_49833978 | 0.46 |
ENST00000020945.1 |
SNAI2 |
snail family zinc finger 2 |
chr16_+_8768422 | 0.46 |
ENST00000268251.8 ENST00000564714.1 |
ABAT |
4-aminobutyrate aminotransferase |
chr10_-_126847276 | 0.45 |
ENST00000531469.1 |
CTBP2 |
C-terminal binding protein 2 |
chr1_+_203097407 | 0.43 |
ENST00000367235.1 |
ADORA1 |
adenosine A1 receptor |
chr1_+_201979645 | 0.43 |
ENST00000367284.5 ENST00000367283.3 |
ELF3 |
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr4_-_83765613 | 0.43 |
ENST00000503937.1 |
SEC31A |
SEC31 homolog A (S. cerevisiae) |
chr2_+_162087577 | 0.42 |
ENST00000439442.1 |
TANK |
TRAF family member-associated NFKB activator |
chr8_-_13372395 | 0.42 |
ENST00000276297.4 ENST00000511869.1 |
DLC1 |
deleted in liver cancer 1 |
chrX_-_11284095 | 0.41 |
ENST00000303025.6 ENST00000534860.1 |
ARHGAP6 |
Rho GTPase activating protein 6 |
chr1_-_94079648 | 0.41 |
ENST00000370247.3 |
BCAR3 |
breast cancer anti-estrogen resistance 3 |
chr12_+_15699286 | 0.40 |
ENST00000442921.2 ENST00000542557.1 ENST00000445537.2 ENST00000544244.1 |
PTPRO |
protein tyrosine phosphatase, receptor type, O |
chr19_+_35629702 | 0.40 |
ENST00000351325.4 |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
chr1_+_156096336 | 0.39 |
ENST00000504687.1 ENST00000473598.2 |
LMNA |
lamin A/C |
chr1_-_27240455 | 0.37 |
ENST00000254227.3 |
NR0B2 |
nuclear receptor subfamily 0, group B, member 2 |
chr1_+_150245177 | 0.37 |
ENST00000369098.3 |
C1orf54 |
chromosome 1 open reading frame 54 |
chr10_+_28966271 | 0.36 |
ENST00000375533.3 |
BAMBI |
BMP and activin membrane-bound inhibitor |
chr7_-_151217166 | 0.34 |
ENST00000496004.1 |
RHEB |
Ras homolog enriched in brain |
chr6_-_6007200 | 0.34 |
ENST00000244766.2 |
NRN1 |
neuritin 1 |
chr17_+_42264322 | 0.34 |
ENST00000446571.3 ENST00000357984.3 ENST00000538716.2 |
TMUB2 |
transmembrane and ubiquitin-like domain containing 2 |
chr8_-_62602327 | 0.33 |
ENST00000445642.3 ENST00000517847.2 ENST00000389204.4 ENST00000517661.1 ENST00000517903.1 ENST00000522603.1 ENST00000522349.1 ENST00000522835.1 ENST00000541428.1 ENST00000518306.1 |
ASPH |
aspartate beta-hydroxylase |
chr8_+_74903580 | 0.32 |
ENST00000284818.2 ENST00000518893.1 |
LY96 |
lymphocyte antigen 96 |
chr19_+_35630022 | 0.32 |
ENST00000589209.1 |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
chr12_+_21207503 | 0.31 |
ENST00000545916.1 |
SLCO1B7 |
solute carrier organic anion transporter family, member 1B7 (non-functional) |
chr7_-_27169801 | 0.29 |
ENST00000511914.1 |
HOXA4 |
homeobox A4 |
chr17_+_7788104 | 0.28 |
ENST00000380358.4 |
CHD3 |
chromodomain helicase DNA binding protein 3 |
chr3_+_46924829 | 0.28 |
ENST00000313049.5 |
PTH1R |
parathyroid hormone 1 receptor |
chr1_+_156095951 | 0.26 |
ENST00000448611.2 ENST00000368297.1 |
LMNA |
lamin A/C |
chr5_+_140552218 | 0.26 |
ENST00000231137.3 |
PCDHB7 |
protocadherin beta 7 |
chr22_-_31742218 | 0.26 |
ENST00000266269.5 ENST00000405309.3 ENST00000351933.4 |
PATZ1 |
POZ (BTB) and AT hook containing zinc finger 1 |
chr15_+_80364901 | 0.25 |
ENST00000560228.1 ENST00000559835.1 ENST00000559775.1 ENST00000558688.1 ENST00000560392.1 ENST00000560976.1 ENST00000558272.1 ENST00000558390.1 |
ZFAND6 |
zinc finger, AN1-type domain 6 |
chr17_-_36891830 | 0.23 |
ENST00000578487.1 |
PCGF2 |
polycomb group ring finger 2 |
chr7_-_151217001 | 0.23 |
ENST00000262187.5 |
RHEB |
Ras homolog enriched in brain |
chr3_-_27498235 | 0.21 |
ENST00000295736.5 ENST00000428386.1 ENST00000428179.1 |
SLC4A7 |
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
chr10_-_74114714 | 0.20 |
ENST00000338820.3 ENST00000394903.2 ENST00000444643.2 |
DNAJB12 |
DnaJ (Hsp40) homolog, subfamily B, member 12 |
chr2_+_113403434 | 0.19 |
ENST00000272542.3 |
SLC20A1 |
solute carrier family 20 (phosphate transporter), member 1 |
chr14_+_100150622 | 0.19 |
ENST00000261835.3 |
CYP46A1 |
cytochrome P450, family 46, subfamily A, polypeptide 1 |
chr1_+_150245099 | 0.19 |
ENST00000369099.3 |
C1orf54 |
chromosome 1 open reading frame 54 |
chr17_-_34344991 | 0.18 |
ENST00000591423.1 |
CCL23 |
chemokine (C-C motif) ligand 23 |
chr17_+_42264556 | 0.17 |
ENST00000319511.6 ENST00000589785.1 ENST00000592825.1 ENST00000589184.1 |
TMUB2 |
transmembrane and ubiquitin-like domain containing 2 |
chr15_-_52821020 | 0.17 |
ENST00000553916.1 |
MYO5A |
myosin VA (heavy chain 12, myoxin) |
chr12_-_125401885 | 0.16 |
ENST00000542416.1 |
UBC |
ubiquitin C |
chr1_+_24018269 | 0.15 |
ENST00000374550.3 |
RPL11 |
ribosomal protein L11 |
chr7_+_120629653 | 0.15 |
ENST00000450913.2 ENST00000340646.5 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
chr9_-_33402506 | 0.15 |
ENST00000377425.4 ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7 |
aquaporin 7 |
chr3_-_47934234 | 0.15 |
ENST00000420772.2 |
MAP4 |
microtubule-associated protein 4 |
chr12_+_12938541 | 0.14 |
ENST00000356591.4 |
APOLD1 |
apolipoprotein L domain containing 1 |
chr17_-_34345002 | 0.13 |
ENST00000293280.2 |
CCL23 |
chemokine (C-C motif) ligand 23 |
chr12_+_20963647 | 0.13 |
ENST00000381545.3 |
SLCO1B3 |
solute carrier organic anion transporter family, member 1B3 |
chr12_+_20963632 | 0.13 |
ENST00000540853.1 ENST00000261196.2 |
SLCO1B3 |
solute carrier organic anion transporter family, member 1B3 |
chr12_+_110562135 | 0.12 |
ENST00000361948.4 ENST00000552912.1 ENST00000242591.5 ENST00000546374.1 |
IFT81 |
intraflagellar transport 81 homolog (Chlamydomonas) |
chr22_+_41258250 | 0.11 |
ENST00000544094.1 |
XPNPEP3 |
X-prolyl aminopeptidase (aminopeptidase P) 3, putative |
chrX_+_119384607 | 0.11 |
ENST00000326624.2 ENST00000557385.1 |
ZBTB33 |
zinc finger and BTB domain containing 33 |
chr17_-_10276319 | 0.11 |
ENST00000252172.4 ENST00000418404.3 |
MYH13 |
myosin, heavy chain 13, skeletal muscle |
chr1_+_221051699 | 0.10 |
ENST00000366903.6 |
HLX |
H2.0-like homeobox |
chr1_-_169703203 | 0.10 |
ENST00000333360.7 ENST00000367781.4 ENST00000367782.4 ENST00000367780.4 ENST00000367779.4 |
SELE |
selectin E |
chr1_+_36621697 | 0.10 |
ENST00000373150.4 ENST00000373151.2 |
MAP7D1 |
MAP7 domain containing 1 |
chr14_+_72052983 | 0.09 |
ENST00000358550.2 |
SIPA1L1 |
signal-induced proliferation-associated 1 like 1 |
chr20_+_11898507 | 0.07 |
ENST00000378226.2 |
BTBD3 |
BTB (POZ) domain containing 3 |
chr21_+_19617140 | 0.07 |
ENST00000299295.2 ENST00000338326.3 |
CHODL |
chondrolectin |
chr16_+_84328252 | 0.07 |
ENST00000219454.5 |
WFDC1 |
WAP four-disulfide core domain 1 |
chr3_+_121311966 | 0.07 |
ENST00000338040.4 |
FBXO40 |
F-box protein 40 |
chr14_+_56078695 | 0.07 |
ENST00000416613.1 |
KTN1 |
kinectin 1 (kinesin receptor) |
chr1_-_46642154 | 0.06 |
ENST00000540385.1 |
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr12_-_45269430 | 0.06 |
ENST00000395487.2 |
NELL2 |
NEL-like 2 (chicken) |
chr1_+_151129135 | 0.06 |
ENST00000602841.1 |
SCNM1 |
sodium channel modifier 1 |
chr9_-_215744 | 0.05 |
ENST00000382387.2 |
C9orf66 |
chromosome 9 open reading frame 66 |
chrX_+_18725758 | 0.05 |
ENST00000472826.1 ENST00000544635.1 ENST00000496075.2 |
PPEF1 |
protein phosphatase, EF-hand calcium binding domain 1 |
chr10_+_52750930 | 0.04 |
ENST00000401604.2 |
PRKG1 |
protein kinase, cGMP-dependent, type I |
chr18_-_64271363 | 0.04 |
ENST00000262150.2 |
CDH19 |
cadherin 19, type 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.5 | 5.9 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.3 | 3.8 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.1 | 15.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.1 | 3.2 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
1.0 | 3.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.6 | 1.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.6 | 3.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.5 | 3.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 1.9 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.5 | 5.1 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.4 | 2.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 2.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 5.3 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.4 | 1.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 1.5 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.4 | 24.4 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.3 | 3.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.3 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 1.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.3 | 1.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 1.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 2.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 1.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 1.0 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.3 | 1.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 5.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.9 | GO:0097338 | response to clozapine(GO:0097338) |
0.2 | 0.5 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.2 | 4.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 3.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 3.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.8 | GO:1903279 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 12.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.4 | GO:0032900 | regulation of nucleoside transport(GO:0032242) negative regulation of neurotrophin production(GO:0032900) |
0.1 | 1.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 19.6 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 1.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.4 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.1 | 1.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.1 | 0.6 | GO:0032571 | response to vitamin K(GO:0032571) response to hydroxyisoflavone(GO:0033594) |
0.1 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 2.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.5 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) positive regulation of prolactin secretion(GO:1902722) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.1 | 1.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 1.6 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 0.5 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.1 | 1.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.6 | GO:1990822 | L-cystine transport(GO:0015811) basic amino acid transmembrane transport(GO:1990822) |
0.1 | 2.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 7.0 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 0.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 2.7 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.1 | 1.4 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 1.1 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 3.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 2.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 1.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 4.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 3.9 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 1.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0051643 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) secretory granule localization(GO:0032252) endoplasmic reticulum localization(GO:0051643) |
0.0 | 2.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 5.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 2.7 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 1.0 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 2.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 1.2 | GO:0061053 | somite development(GO:0061053) |
0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 2.9 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.0 | 2.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 2.0 | GO:0060047 | heart contraction(GO:0060047) |
0.0 | 4.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 2.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.7 | 10.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
1.4 | 24.8 | GO:0005861 | troponin complex(GO:0005861) |
1.3 | 5.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.1 | 6.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.8 | 2.5 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.6 | 2.5 | GO:0045160 | myosin I complex(GO:0045160) |
0.6 | 21.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 3.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 5.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 2.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 8.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 2.5 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.3 | 1.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 2.5 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.2 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.2 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 22.4 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 4.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 3.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 4.6 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 1.3 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 2.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 4.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 4.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 1.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.7 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 5.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 3.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.0 | 0.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 2.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 48.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 3.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 4.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 10.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 4.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 2.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 4.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 2.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 1.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 3.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 2.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 14.5 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 3.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.8 | 4.1 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.8 | 2.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 2.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 3.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 1.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.5 | 18.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 2.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.5 | 3.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 2.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.5 | 2.8 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.5 | 10.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 1.4 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.3 | 3.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 1.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 18.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 3.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.2 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 2.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 9.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 3.5 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 1.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 10.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 3.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 1.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 4.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 22.8 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 2.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 1.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 1.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 6.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 3.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 6.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 19.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 2.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 3.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 3.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 2.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 2.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 2.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 3.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 3.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 4.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |